1. Analysis of the drug value chain
-
The pharmaceutical industry, structured around treatments for major diseases, has undergone several profound transformations over the past two decades:
several waves of mergers and acquisitions have led to a concentration of pharmaceutical companies, which have refocused on their core business: the research and development of pharmaceutical specialties. The top five groups worldwide will have a 20% market share in 2023, and four of them are American;
longer research and development (R&D) times, leading to increasingly high costs for finding new treatments: on average, it takes just over 10 years of R&D, followed by 3 years of administrative procedures before a drug can be brought to market;
an increase in the number of subcontractors in emerging...
The Ultimate Scientific and Technical Reference
This article is included in
Logistics and Supply Chain
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Analysis of the drug value chain
Analysis of players in the French market
Bibliography
- (1) - LEEM - Le marché pharmaceutique. - Article consultable en ligne https://urlr.me/xfw3v7
- (2) - TIWARI (S.), WEE (H.M.), DARYANTO (Y.) - Big Data Analytics in Supply Chain Management...
Regulations
Public Health Code (article L. 5111-1)
Public Health Code (article L. 5136-1)
Public Health Code (article L. 5124-17-2)
Guidelines published by the European Commission (2013/C 68/01 and 2013/C 343/01 of November 5, 2013).
Decree no. 2016-993 of July 20, 2016 on the fight against drug supply shortages. NOR : AFSP1605997D. JORF...
The Ultimate Scientific and Technical Reference
